Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
OBJECTIVE
To assess the impact of the introduction of new medical methods on the provision of therapeutic abortions at the Royal Infirmary Edinburgh.


METHODS
A review of the total number of abortions performed by medical and surgical means between 1989 and 1995 (inclusive); a prospective survey of the terminations of pregnancy (< or = 9 weeks of gestation) performed over the six-month period of January to June 1994; and a questionnaire of the reasons why women chosen a particular method.


METHODS
Large teaching hospital in Scotland.


METHODS
One thousand and seven women seeking early pregnancy termination between January and June 1994.


METHODS
Proportion of pregnancies terminated by medical means; comparison of complete abortion rate, incidence of complications and morbidity following both medical and surgical methods (< or = 9 weeks of gestation); reasons for preference of the method of abortion.


RESULTS
Since 1991 there has been a progressive increase in the number of medical abortions performed at the Royal Infirmary of Edinburgh, and by 1994 the majority of women (57%) seeking abortion at < or = 9 weeks chose a medical method. Women who chose medical abortion had more years at full-time education and were less likely to smoke (P < 0.04). Both medical and surgical methods were highly effective (> 96% complete abortion) with a low incidence of complications and morbidity. However, women who had chosen the medical method were less likely to receive antibiotics for suspected endometritis than their surgical counterparts (chi 2, P = 0.0001).


CONCLUSIONS
If this trend towards medical methods in Edinburgh is repeated elsewhere, it will inevitably have an impact on gynaecological services by releasing staff and operating time for other purposes.
Cameron
S T
ST
Department of Obstetrics and Gynaecology, University of Edinburgh, UK.
Glasier
A F
AF
Logan
J
J
Benton
L
L
Baird
D T
DT
D000021:Abortifacient Agents, Steroidal; D000032:Abortion, Therapeutic / Q000009:adverse effects / Q000379:methods*; D000328:Adult; D005260:Female; D006801:Humans; D015735:Mifepristone; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011446:Prospective Studies; D012606:Scotland; D014620:Vacuum Extraction, Obstetrical
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone